Humira Buyers Take AbbVie Antitrust Challenge To 7th Circ.
By Khorri Atkinson · July 30, 2020, 6:18 PM EDT
Humira buyers are appealing to the Seventh Circuit an Illinois federal judge's dismissal of their proposed class action claiming AbbVie Inc. built a "patent thicket" around the immunosuppressant drug to block...
To view the full article, register now.